SCHEMBL18323127

SCHEMBL18323127

COc1ncncc1C(=O)Nc1cc(Br)c(S(N)(=O)=O)cn1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP3K5 Q99683 1/20 0.39
▸ RAB9A P51151 5/20 0.36
▸ NPC1 O15118 4/20 0.36
▸ MITF O75030 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ F10 P00742 6/20 0.35
▸ KLK1 P06870 1/20 0.35
▸ ABCB1 P08183 1/20 0.33
▸ ABCC1 P33527 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ GPR6 P46095 1/20 0.33
▸ RXFP1 Q9HBX9 1/20 0.33
▸ CYP17A1 P05093 1/20 0.33
▸ CA12 O43570 1/20 0.33
▸ CA1 P00915 1/20 0.33
▸ CA2 P00918 1/20 0.33
▸ CA3 P07451 1/20 0.33
▸ CA4 P22748 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15907220 0.84 MAP3K5 (0.43) MAP3K5RAB9ANPC1MITFKMT2A
SCHEMBL18323181 0.78 ATR (0.37) RAB9ANPC1KMT2AMEN1CA1
SCHEMBL18323142 0.74 MAP3K5 (0.34) MAP3K5
SCHEMBL18323129 0.70 F10 (0.45) MAP3K5RAB9ANPC1KMT2AMEN1
SCHEMBL18323128 0.69 NPC1 (0.52) RAB9ANPC1KMT2AMEN1F10
SCHEMBL15907231 0.68 MAP3K5 (0.42) MAP3K5RAB9ANPC1MITFKMT2A
SCHEMBL30962826 0.68 PDE4D (0.43) MAP3K5KMT2A
SCHEMBL18323130 0.67 NPC1 (0.36) MAP3K5RAB9ANPC1KMT2AMEN1
SCHEMBL31582882 0.66 NNMT (0.45) MAP3K5GAAHPGD
SCHEMBL30509874 0.66 NNMT (0.45) MAP3K5GAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9522910-B2 Protein kinase inhibitors (variants), use thereof in treating oncological diseases and a pharmaceutical composition based thereon Obshchestvo s ogranichennoy otvetstvennostyou “Fusion Pharma” (RU) 2016-12-20 — — US disclosed
Send feedback